1) giant particle,hot particle
强放射性粒子
2) giant particle (GP)
(核爆炸沉降物中)强放射性粒子
3) Intensity-modulated radiation therapy
调强放疗
1.
Comparison of 3-dimension conformal and intensity-modulated radiation therapy plans for rectum cancer;
直肠癌三维适形和调强放疗物理计划的比较研究
2.
Background and Objective: Intensity-modulated radiation therapy (IMRT) is a new irradiation technique developed to improve target dose conformity and normal tissue sparing.
但是,在调强放疗这种复杂的照射技术实施过程中,每分次照射时间较常规放疗明显延长,这可能导致其辐射生物学效应发生显著改变。
4) intensity modulated radiation therapy
调强放疗
1.
Improved simulate annealing algorithm for therapy planning optimization in intensity modulated radiation therapy;
调强放疗治疗计划制定中的改进模拟退火算法
2.
Objective: To investinate the short-term effects of Intensity modulated radiation therapy (IMRT)on recurrent Cervical Cancer in pelvis.
方法:17例盆腔复发宫颈癌患者给予调强放疗。
3.
Systematic setup errors for intensity modulated radiation therapy in the nasopharyngeal carcinoma:effect on dose distribution;
背景与目的:目前调强放疗已广泛应用于鼻咽癌,与传统放疗相比,调强放疗对摆位精确度要求更高。
5) IMRT
调强放疗
1.
Methods and techniques for precise verification of IMRT dose distribution using DVS.;
利用DVS对调强放疗计划剂量分布精确验证的方法与技巧
2.
Optimization of IMRT based on scaled conjugate gradient algorithm;
基于SCG算法的调强放疗计划优化
3.
Comparison of the irradiation doses for IMRT and conventional radiotherapy in nasopharyngeal carcinoma patients;
鼻咽癌调强放疗和常规放疗受照剂量对比分析
6) intensity modulated radiotherapy
调强放疗
1.
From simple superfical X ray machines to intensity modulated radiotherapy: brief introduction for the Department of Radiation Oncology of the Cancer Hosptial of Fudan University;
从浅部X线到调强放疗——复旦大学附属肿瘤医院放疗科发展简史
2.
[Purpose] To investigate the set-up error in intensity modulated radiotherapy (IMRT) with electric portal image device (EPID) in nasopharyngeal carcinoma (NPC).
[目的]用电子射野图像器件(EPID)拍摄的射野片研究调强放疗治疗鼻咽癌过程中的摆位误差。
参考词条
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。